In addition, as a group of immunosuppressive lymphocytes, Foxp3+TILs alone didn't show any prognostic effects in patients with stage I NSCLC, but was associated with DFS when combined with CD8+TILs. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.